Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Yttrium Y-90 clivatuzumab tetraxetan |
Trade Name | |
Synonyms | IMMU-107|90Y-hPAM4 |
Drug Descriptions |
Yttrium Y-90 clivatuzumab tetraxetan (IMMU-107) consists of an anti-MUC1 antibody conjugated to radioactive yttrium Y 90, which binds and delivers cytotoxic radiation to MUC1-expressing tumor cells (PMID: 26187510). |
DrugClasses | |
CAS Registry Number | 943976-23-6 |
NCIT ID | C48429 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Yttrium Y-90 clivatuzumab tetraxetan | Yttrium Y-90 clivatuzumab tetraxetan | 0 | 1 |